First mRNA flu shot gets FDA approval, raising hopes for a more effective vaccine
β’ The FDA has approved the first-of-its-kind mRNA-based flu vaccine specifically for adults aged 50 and older. β’ This approval follows a severe 2024-25 flu season, which the CDC estimates resulted in approximately 45,000 deaths. β’ The shift to mRNA technology is significant as it offers the potential for more effective, rapidly adaptable vaccines compared to traditional methods.
cidrap.umn.edu

